The cost of extended-release amphetamine dextroamphetamine varies depending on factors such as dosage, formulation, and insurance coverage.
What influences the price of extended-release amphetamine dextroamphetamine?
The price of extended-release amphetamine dextroamphetamine is affected by several factors. These include the specific milligram strength of the medication, the number of pills in a prescription, and whether the patient is using a generic or brand-name version [1]. Insurance plans also play a significant role, with co-pays differing widely between plans. Without insurance, the out-of-pocket cost can be considerably higher [2].
How does generic versus brand-name affect cost?
Generic versions of extended-release amphetamine dextroamphetamine are generally less expensive than their brand-name counterparts. Once a patent expires, other manufacturers can produce generic versions, which typically drives down the overall cost for consumers [3].
When might patent expiry impact the cost?
Patent expiry is a key event that can lead to lower costs for medications like extended-release amphetamine dextroamphetamine. For example, if the patent for a specific formulation of extended-release amphetamine dextroamphetamine expires, generic manufacturers can enter the market. This increased competition often results in reduced prices. Information on patent timelines for specific drugs can be found through resources like DrugPatentWatch.com [4].
What are the typical price ranges for this medication?
Without insurance, the cost for a 30-day supply of extended-release amphetamine dextroamphetamine can range from approximately $150 to over $400, depending on the specific product and pharmacy [2]. With insurance, co-pays can be as low as $10 to $50 for a 30-day supply, though this is highly dependent on the insurance plan's formulary and deductible [1][2].
Can discount cards or coupons lower the price?
Yes, discount cards and manufacturer coupons can help reduce the out-of-pocket cost for extended-release amphetamine dextroamphetamine. These programs are often available to patients, even those with insurance, to lower co-pays or provide a discount on cash prices [1][2].
---
Sources:
1. https://www.goodrx.com/amphetamines-mixed-salts-er
2. https://www.singlecare.com/prescription/amphetamine-dextroamphetamine-er
3. https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/abbreviated-new-drug-applications-andanda
4. https://drugpatentwatch.com/